THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)

– THERAKOS, the world’s only fully integrated and validated Extracorporeal Photopheresis (ECP) system,1 received this CE certificate under the EU’s new and more rigorous certification process –  DUBLIN, Sept. 3, 2024 /PRNewswire/ — Mallinckrodt plc, a global specialty pharmaceutical company, announced that the THERAKOS™ CELLEX™ Photopheresis System has obtained CE Certification under the updated European Union […] L'articolo THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR) proviene da La Ragione.

CONTINUA A LEGGERE